T/JPMA 032-2025 Technical Specifications for the Detection of Human-derived Drug-Resistant Bacteria in the Intestinal Tract
T/JPMA 032-2025 The technical specifications for detecting resistant bacteria in human gut microbiota can be divided into four categories
Basic Information
Scope
Scope: This document specifies the equipment and materials, culture media and reagents, sample collection, storage and transportation, strain isolation and identification, drug susceptibility testing, quality control, result interpretation and reporting, and biosafety requirements for the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. This document is applicable to the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. Main technical content: This document specifies the equipment and materials, culture media and reagents, sample collection, storage and transportation, strain isolation and identification, drug susceptibility testing, quality control, result interpretation and reporting, and biosafety requirements for the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. This document is applicable to the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci.